مقالات منتشر شده
فهرست زیر شامل منتخبی از مقالات منتشرشده در مجلات معتبر پزشکی است که به موضوعاتی مانند سندرم روده تحریک‌پذیر، بیماری‌های التهابی روده، نفوذپذیری دستگاه گوارش و فناوری‌های جدید در زمینه پزشکی می‌پردازد و طیف وسیعی از بیماری‌های گوارش و کبد را در بر می‌گیرد. استفاده از برخی از این مقالات به طور گسترده توسط دیگر پژوهشگران به عنوان منبع مورد استناد، حاکی از نقش مؤثر این تحقیقات پایه‌ای در پیشرفت طب بالینی، توسعه روشهای نوین تشخیصی و بهبود درمان‌های موجود برای بیماری‌های گوارش و کبد است
علاوه بر این، مقالات اخیر در زمینه تحقیقات روان-اجتماعی و مطالعات هوشیاری نمایانگر ارتباط تنگاتنگ بین حوزه پزشکی، روانشناسی و فلسفه هوشیاری است. این پژوهش‌ها چشم‌انداز پزشکی را فراتر از مرزهای سنتی آن گسترش داده و با ترکیب بینش‌های علمی و فلسفی، درک جامع‌تری از سلامت و بهزیستی انسان را ارائه می‌دارد
Articles:
1. Farhadi, A. Shell and Core Model of Subjective Well-Being: Extending the Reach of Happiness Beyond the Field of Positive Psychology. Neuropsychiatry 2023, 13(4) https://www.jneuropsychiatry.org/peer-review/shell-and-core-model-of-subjective-wellbeing-extending-the-reach-of-happiness-beyond-the-field-of-positive-psychology-16968.html
2. Farhadi, A. The Evolution of Consciousness Theories. Preprints 2022, 2022110330. https://doi.org/10.20944/preprints202211.0330.v1
3. Farhadi, A. Physical Libertarianism: Redeeming the Illusion of Free Will Back into Reality. J Psych Neurchem Res 1(3):1-11. https://mkscienceset.com/articles_file/834-_article1701844299.pdf.Preprints 2022, 2022060136 (doi: 10.20944/preprints202206.0136.v1).
4. Farhadi, A. Trilogy: A New Paradigm of Consciousness. Neuropsychiatry 2023 13(5): 1-15. https://www.jneuropsychiatry.org/peer-review/trilogy-a-new-paradigm-of-consciousness-17097.html
5. Farhadi A. There is no “I” in “AI”. AI & Soc (2021). https://doi.org/10.1007/s00146-020-01136-2
6. Farhadi A. Nuances in Irritable Bowel Syndrome. CoastLines; Physician Newsletter. 2019; March 3(22): 1-9.
7. Farhadi A. Is Happiness Overrated? The Duality of Reasons Behind Our Actions. International Journal of Medical Science and Health Research. 2019; March 3(2): 63-68.
8. Farhadi A. Exploring the Self-Reported Well-Being Attributes in Anxiety and Depression. Open Science Journal of Psychology. 2018; 5(3): 28-37.
9. Farhadi A, Banton D, Keefer L. Connecting our gut feeling and how our gut feels: The role of well-being attributes in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018;2: 289-298.
10. Farhadi A, Mobarhan S. The Factors Involved in the Sense of Subjective Wellbeing (A Survey of 250 Subjects). World J Social Sci. 2017 Jan 4;1;14-21.
11. Farhadi A, Saadat V, Ewer R. Whole colonic endoscopic ultrasound using a novel device: In Vivo Animal Study. J. Gastrointetinal Endoscopy. 2016 Dec 1;4;70-1.
12. Farhadi A. Non-Chemical Distant Cellular Interactions as a potential confounder of cell biology experiments. Front Physiol. 2014 Oct 17;5:405.
13. Swanson GR, Sedghi S, Farhadi A, Keshavarzian A. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol. 2010 May;44(3):223-8.
14. Cifra M, Fields JZ, Farhadi A. Electromagnetic cellular interactions. Prog Biophys Mol Biol. 2011 May;105(3):223-46
15. Farhadi A, Keshavarzian A, Kwasny MJ, Shaikh M, Fogg L, Lau C, Fields JZ, Forsyth CB. Effects of aspirin on gastroduodenal permeability in alcoholics and controls. Alcohol. 2010 Aug;44(5):447-56.
16. Singhal S, Dian D, Keshavarzian A, Fogg L, Fields JZ, Farhadi A. The Role of Oral Hygiene in Inflammatory Bowel Disease. Dig Dis Sci. 2010 May 11.
17. Tang Y, Forsyth CB, Farhadi A, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, Keshavarzian A. Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res. 2009 Jul;33(7):1220-30.
18. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009 Mar;43(2):163-72.
19. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009 Mar;50(3):538-47.
20. Haddish-Berhane N, Farhadi A, Nyquist C, Haghighi K, Keshavarzian A. SIMDOT-AbMe: microphysiologically based simulation tool for quantitative prediction of systemic and local bioavailability of targeted oral delivery formulations. Drug Metab Dispos. 2009 Mar;37(3):608-18.
21. Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: a possible mechanism for endotoxemia in nonalcoholic steatohepatitis. Liver Int. 2008 Aug;28(7):1026-33.
22. Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 100: 49-53, 2008.
23. Craven M, Chandler ML, Steiner JM, Farhadi A, Welsh E, Pratschke K, Shaw DJ, Williams DA. Acute effects of carprofen and meloxicam on canine gastrointestinal permeability and mucosal absorptive capacity. J Vet Intern Med. 21: 917-23, 2007.
24. Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 22: 1748-53, 2007.
25. Farhadi A, Keshavarzian A, Shaikh M, Banan A, Fields J, Banan A. Reduced immunostaining for c-kit receptors in mucosal mast cells in Inflammatory Bowel Diseases. J Gastroenterol Hepatol. 22: 2338-43, 2007.
26. Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol. 14: 3027-30, 2007.
27. Ranjbaran Z, Keefer L, Stepenski E, Farhadi A, Keshavarzian A. The relevance of sleep to chronic inflammatory conditions. Inflamm. res. 56: 51–7, 2006.
28. Farhadi A, Forsyth C, Banan A, Shaikh M, Engen P, Fields JZ, Keshavarzian A. Evidence for non-chemical, non-electrical intercellular signaling in intestinal epithelial cells. Bioelectrochemistry. 71: 142-8, 2007.
29. Haddish NB, Nyquist C, Haghighi K, Corvalan C, Keshavarzian A,Campanella O, Rickus J, Farhadi A. Biological variability and targeted delivery of therapeutics for Inflammatory Bowel Diseases: an in silico approach. Inflamm Allergy Drug Targets. 6: 47-55, 2007.
30. Forsyth CB, Banan A, Farhadi A, Fields JZ, Tang Y, Shaikh M, Zhang L, Engen PA, Keshavarzian A.Regulation of Oxidant-induced Intestinal Permeability by Metalloprotease-Dependent EGFR Signaling. J Pharmacol Exp Ther. 321: 84-97, 2007.
31. Farhadi A, Keshavarzian A, Fields J, Sheikh M, Banan A. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatography. J Chromatography B Analyt Technol Biomed Life Sci. 836: 63-8, 2006.
32. Haddish NB, Nyquist C, Haghighi K, Corvalan C, Keshavarzian A,Campanella O, Rickus J, Farhadi A. A multi-scale stochastic drug release model for colon targeted drug delivery systems. J Control Release. 110 (2): 314-22, 2005.
33. Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields J. Heightened Responses to Stressor in Patients with Inflammatory Bowel Disease. Am J Gastro, 2005;100:1796–1804.
34. Farhadi A, Keshavarzian A, Ranjbaran Z, Fields JZ, Banan A. Role of PKC isoforms in modulation of injury and repair of intestinal barrier function. J Pharmacol Exp Ther. 316 (1): 1-7, 2005.
35. Banan A, Zhang LJ, Shaikh M, Fields JZ, Choudhary S, Forsyth CB, Farhadi A, Keshavarzian A. Theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther. 2005 Jun;313(3):962-82.
36. Banan A, Zhang L, Farhadi A, Fields JZ, Shaikh M, Forsyth CB, Choudhary S, Keshavarzian A. Critical Role of the Atypical Lambda Isoform of PKC in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Function of Intestinal Epithelium. J Pharmacol Exp Ther. 2005 Feb;312(2):458-71.
37. Banan A, Zhang LJ, Fields JZ, Farhadi A, Shaikh M, Keshavarzian A. A Novel Effect of NF-kB Activation: Carbonylation and Nitration Injury to The Cytoskeleton and Disruption of Monolayer Barrier in Intestinal Epithelium. Am J Physiol Cell Physiol. 287 (4): 1139-51, 2004.
38. Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Theta-isoform of PKC is required for alterations in cytoskeletal dynamics and barrier permeability in intestinal epithelium: a novel function for PKC-theta. Am J Physiol Cell Physiol. 287(1): C18-34, 2004.
39. Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Inhibition of oxidant-induced nuclear factor-kappaB activation and inhibitory-kappaBalpha degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor: key role of phospholipase-gamma isoform. J Pharmacol Exp Ther. 2004 Apr;309(1):356-68.
40. Farhadi A, Banan A, Keshavarzian A. Role of Cytoskeletal Structure in Modulation of Intestinal Permeability. AIMJ, Vol 6 (1): 49-53, 2003.
41. Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Keshavarzian A.PKC-b1 Isoform Activation is Required for EGF-Induced NF-kB Inactivation and I-kBa Stabilization and Protection of F-Actin Assembly and Barrier Function in Enterocyte Monolayers. Am J Physiol Cell Physiol. 286 (3): 723-38, 2003.
42. Banan A, Fields JZ, Zhang LJ, Shaikh M, Farhadi A, Keshavarzian A. Zeta isoform of protein kinase C prevents oxidant-induced NF-kB activation and I-kBa degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity. J Pharmacol Exp Ther. 307(1): 2003, 53-66.
43. Banan A, Farhadi A, Fields JZ, Mutlu E, Zhang L, Keshavarzian A. Evidence That NF-kB Activation Is Critical in Oxidant-Induced Disruption of The Microtubule Cytoskeleton & Barrier Integrity and That Its Inactivation Is Essential in EGF-Mediated Protection of The Monolayers of Intestinal Epithelia. J Pharmacol Exp Ther. Vol 306 (1): 13-28, 2003.
44. Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Key role of PLC-g in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly. Am J Physiol Cell Physiol. 285(4): 977-93, 2003.
45. Farhadi A, Fields J, Banan A, Keshavarzian A. Intestinal Barrier: An interface between health and disease. J Gastroenterol Hepatol, Vol 18(5): 479-97, 2003.
46. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Zhang Y, Fields JZ. Increases in Colonic Free Radicals and in Cytoskeletal Protein Oxidation and Nitration in Inflammatory Bowel Disease. Gut Vol 52(5), 720-8, 2003.
47. Banan A, Farhadi A, Fields JZ, Zhang LJ, Shaikh M, Keshavarzian A. The Delta isoform of PKC Causes iNOS and NO Upregulation: Key Mechanism for Oxidant-induced Carbonylation, Nitration and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia. J Pharmacol Exp Ther. Vol 305 (2): 482-94, 2003.
48. Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, Banan A. Gas Chromatographic Method for Detection of Urinary Sucralose; Application to the Assessment of Intestinal Permeability. J Chromatography B, Vol 784(1): 145-54, 2003.
49. Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, Keshavarzian A. Activation of delta-isoform of protein kinase C is required for oxidant-induced disruption of both the microtubule cytoskeleton and permeability barrier of intestinal epithelia. J Pharmacol Exp Ther. Vol 303 (1): 17-28, 2002.
50. Banan A, Zhang L, Fields JZ, Farhadi A, Talmage DA, , Keshavarzian A. PKC-zeta prevents oxidant-induced iNOS upregulation and protects the microtubules and gut barrier integrity. Am J Physiol (GI & Liver), Vol 283(4): 909-22, 2002.
51. Farhadi A, Keshavarzian A, Banan A, Zhang Y, Fitzpatrick LF. The Modulatory Effects of Plasma and Colonic Milieu of patients with Ulcerative Colitis on OPC Antioxidants. Dig Dis Sci, Vol 47(6): 1342-8, 2002.
52. Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, Keshavarzian A. The b1 isoform of PKC mediates the protective effects of epidermal growth factor on the dynamic assembly of the F-Actin cytoskeleton and the calcium homeostasis. J Pharmacol Exp Ther, Vol 301(3): 852-66, 2002.
53. Farhadi A, Mutlu E, Keshavarzian A. An Overview of future therapeutic options for IBD. Hospital Pharmacy Europe, Vol 10(5): 1-5, 2003.
54. Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive Oxygen Species: Are they involved in the pathogenesis of GERD, Barrett’s Esophagus, and it’s progression toward esophageal cancer. Am J Gastro, Vol 97(1): 22-6, 2002.
55. Farhadi A, Bruninga K, Keshavarzian A Irritable Bowel Syndrome; new aspects of therapeutic modalities. Expert Opinion on Investigational Drugs, Vol 10(7):1211-22, 2001.
56. Mutlu E, Farhadi A, Keshavarzian A. New Developments in treatment of inflammatory bowel disease. Expert Opinion on Investigational Drugs, Vol 11(3): 365-85, 2002.
57. Farhadi A, Fields J, Bozorgnia SH. Assessment of esophagogastroduodenoscopy tolerance: A prospective study of 300 cases. Diagn Therap Endo, Vol 7(3):141-147, 2001.
58. Farhadi A, Parhizgar A, Rahman S, Haghshenas M. Tuberculosis: The most common cause of fever of undetermined origin in Shiraz. Med J IR Iran, Vol 2: 173-8, 1999. http://pearl.sums.ac.ir/AIM/9924/farhadi9924.html
59. Farhadi A, Omrani GH, Parhizgar A, Haghshenas M. Bone marrow culture versus Widal test in the diagnosis of typhoid fever as a cause of fever of undetermined origin. Iran J Med SCI, Vol 16:132-5, 1991.
60. Omrani GH, Farhadi A, Parhizgar A, Ardehali S, Haghshenas M. Visceral Leishmaniasis as fever of undetermined origin. Med J IR Iran, Vol 8:97-102,1994.
61. Farhadi A, Haghshenas M. Pseudotumor cerebri as the major manifestation of SLE in a case of FUO. Med J IR Iran, Vol 11:259-62, 1997.
62. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Noroozi A. Epidemiology of hepatitis B in Islamic Republic of Iran. Eastern Mediterranean Health J, Vol 2:290-8, 1996. It could be found at address: http://www.emro.who.int/publications/emhj/0202/15.htm.
Abstracts:
¨ Farhadi A, Saadat V, Ewer R. Creating a Hydraulically Sealed Compartment at the Tip of an Endoscope in GI Tract Using a Novel Device: Ex vivo Animal Study. Presentation at the World Congress of Gastroenterology at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2017 Orlando, FL.
¨ Farhadi A, Saadat V, Ewer R. Whole colonic endoscopic ultrasound using a novel device: In Vivo Animal Study. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2016 Las Vegas, NV.
¨ Shaheen S, A, Olenec C, Sotil E, Keshavarzian A. Similarity of Mast Cell density and distribution in terminal ileum and colon of IBD and IBS patients and normal controls. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2009 San Diego, CA.
¨ Singhal S, Farhadi A, Afsharzadeh M, Dian D, Keshavarzian A. The perspective of patient with organic and functional bowel disease on complimentary and alternative medicine. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2008 Orlando, FL.
¨ Singhal S, Farhadi A, Afsharzadeh M, Keshavarzian A. Oral Hygiene and inflammatory bowel disease. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2008 Orlando, FL.
¨ Bajowala S, Farhadi A, Tobin MC. Characterization of Pro- and Anti-Inflammatory Cytokines Produced by Peripheral Blood Lymphocytes in Atopic Individuals with and without Diarrhea –Predominant Irritable Bowel Syndrome. J Allergy and Clin Immunol
¨ Daian D, Farhadi A, Afsharzadeh M, Keshavarzian A. Willingness of individuals with IBD to use Complementary and Alternative Medicine. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2007 Philadelphia, PA.
¨ Haddish NB, Farhadi A, Nyquist C, Haghighi K, Keshavarzian A. Mechanism dependant physiologically-based drug absorption and biotransformation simulation tool (SIMDOT-ABS). AAPS Annual Meeting and Exposition, Nov 2007, Sandiego, CA.
¨ Lau C, Farhadi A, Shaikh M, Banan A. Keshavarzian A. Alcohol-induced upregulation of human intestinal iNOS: possible mechanism of oxidative stress in alcoholic liver disease (ALD). Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Washington, DC, 2007.
¨ Lau C, Farhadi A, Shaikh M, Keshavarzian A. Aspirin challenge unveils susceptibility to colonic hyperpermeability in subjects with alcoholic liver disease. DDW Washington, DC, 2007.
¨ Banan A, Zhang L, Shaikh M, Forsyth CB, Tang Y, Farhadi A, Keshavarzian A. Changes in Activity of The Zeta (ζ) Isoform of PKC Is an Important Determinant of The Inflammatory Pathways: Unique Protective & Modulatory Mechanisms in Gut Epithelium . Washington, DC, 2007.
¨ Banan A, Shaikh M, Zhang L, Forsyth CB, Farhadi A, Mutlu E, Tang Y, Keshavarzian A. A Unique Inflammatory Mechanism for Intestinal Injury During IBD: Modulation of A Distinct Phospholipase C-γ1 (PLC-γ1) Dependent Pathway Could Underlie EGF-Receptor Initiated Pathways That Lead To Mucosal Oxidative Stress And NF-κB Activation In Man. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Washington, DC, 2007.
¨ Banan A, Zhang L, Shaikh M, Forsyth CB, Tang Y, Farhadi A, Keshavarzian A. A Crucial Anti-inflammatory & Barrier Protective Mechanism in Gut Epithelium: PKC-Zeta (ζ) Isoform Is A Key Player in Protection of Cellular Structural Components and Is a Novel Modulator of the I-kB Kinase (I-kK) -α and -β Isotype Pathways. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Washington, DC, 2007.
¨ Forsyth CB, Banan A, Farhadi A, Hayden D, Keshavarzian A. Chemokine Receptor CXCR4 in IBD Patients May Contribute to Progression to Cancer by Stimulating EGFR Signaling and Metalloprotease Expression . Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Washington, DC, 2007.
¨ Banan A, Shaikh M, Zhang L, Fields JZ, Mutlu E, Farhadi A, Forsyth CB, Keshavarzian A. Alterations Of PLC-γ1–PKC Isoform Pathway And The I-kappa B Kinase (I-kK)—NFkB Pathway Predict The Extent Of Mucosal Barrier Protein Isotype Instability in Man: A Novel Barrier Dependent Mechanism For Oxidation And IBD Pathophysiology. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Washington, DC, 2007.
¨ Farhadi A, Keshavarzian A, Jakate S, Shaikh M, Fields JZ, Banan A. Reduced immunostaining of c-kit receptors in mucosal mast cells of IBD patients is not due to mast cell overactivation. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2006 Las Vagas, NV.
¨ Farhadi A, Forsych C, Engen P, Banan A, Shaikh M, Fields JZ, Keshavarzian A. Evidence that a novel, non-chemical, non-electrical intercellular signaling system causes oxidative cytoskeletal damage in distant epithelial cells: Application to modulation of intestinal barrier integrity. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology, Oct 2006 Las Vagas, NV.
¨ Farhadi A, Forsych C, Engen P, Banan A, Shaikh M, Fields JZ, Keshavarzian A. Evidence that a novel non-chemical, non-electrical intercellular signaling system causes oxidative-induced changes in cell protein content and activation of NF-κB in distant epithelial cells. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 130 (4, supp2): T1167, 2006.
¨ Forsych C, Keshavarzian A, Banan A, Farhadi A, Chaudry S. Regulation of intestinal permeability by oxidative and environmental stress via a common metalloproteinase-epidermal growth factor receptor pathway. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 128 (4, supp2): T1728, 2005.
¨ Banan A, Fields JZ, Zhang L, Shaikh M, Farhadi A, Chaudry S, Keshavarzian A. Delta Isoform of PKC (PKC-Delta) Is Critical in the Molecular Disruption of the Intestinal Tight-Junctional Cytoarchitecture and of monolayer barrier function: A unique Mechanism for Epithelial Injury by Oxidant Stress. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 128 (4, supp2): T1723, 2005.
¨ Banan A, Zhang L, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Critical Role of the Atypical Lambda Isoform of PKC (PKC-Lambda) in Disruption of the Cytoskeletal Assembly in Monolayers of Intestinal Epithelium. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 128 (4, supp2): T1722, 2005.
¨ Banan A, Shaikh M, Mutlu E, Farhadi A, Komanduri S, Polzin L, Zhang L, Licardi N, Keshavarzian A. Alterations in NF-kB Signaling (NIK»I-kK»IkB-alpha»NF-kB subunits) Could Explain the Extent of Barrier Tight-Junctional Oxidation & Instability in Mucosa of Patients With Inflammatory Bowel Disease (IBD): A Novel Mechanism for the Pathophysiology of IBD. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 128 (4, supp2): M1075, 2005.
¨ Banan A, Shaikh M, mutlu E, Komanduri S, Farhadi A, Polzin L, Licardi N, Zhang L, Keshavarzian A. Changes in Distinct PKC isoforms – Upregulation of Atypical PKC-Lambda and Downregulation of Classical PKC-Beta-1 Predict Tissue Oxidative Stress and NF-kB Activation in Mucosa of Patients with Inflammatory Bowel Disease (IBD). Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 128 (4, supp2): M1076, 2005.
¨ Farhadi A, Banan A, Fields JZ, Shaikh M, Holmes EW, Keshavarzian A. Commonly used sugars Interfering with Testing for Intestinal Permeability. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro 99(10, supp2), S59, 2004.
¨ Banan A, Zhang L, Farhadi A, Shaikh M, Fields JZ, Keshavarzian A. Fundamental role of NF-kB Activation in Oxidant-induced iNOS Driven Reactions & Oxidative Stress Injury to Cytoskeleton and Barrier Integrity (BI) of Intestinal Epithelium. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Fields JZ, Farhadi A, Zhang L, Keshavarzian A. Zeta (z) & Delta (d) Isoforms of PKC Modulate Intestinal Barrier Function (BF) in Opposing Direction: Molecular Modulation of Tight-Junctional Occludin.Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Zhang L, Farhadi A, Shaikh M, Fields JZ, Keshavarzian A. Theta (q) Isoform of PKC Is A New Modulator of Cytoskeletal Dynamics And A Novel Regulator of Intestinal Monolayer Barrier Function (BF) in Epithelial Cells. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Farhadi A, Fields JZ, Zhang L, Shaikh M, Keshavarzian A. Gamma 1 (g1) isoform of Phospholipase C Uniquely Modulates NF-kB / I-kB-a and Is Key to EGF Protection of Monolayers of Intestinal Epithelium. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Shaikh M, Zhang L, Farhadi A, Fields JZ, Keshavarzian A. Activation of NF-kB pathway (NF-kB Inducing Kinase /NIK, I-kB kinase /Ik-K, I-kBa, NF-kB subunits) And Cytoskeletal Protein Instability in The Mucosa of Patients With Inflammatory Bowel Disease (IBD). Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Shaikh M, Zhang L, Farhadi A, Fields JZ, Keshavarzian A. Changes in Activity of Distinct PKC isoforms Could Explain the Extent of Oxidative Injury & NF-kB Activation in Mucosa of Patients with Inflammatory Bowel Disease (IBD). Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Zhang L, Farhadi A, Shaikh M, Fields JZ, Keshavarzian A. Classical Beta 1 (-b1) Isoform of PKC Is A Novel Modulator of NF-kB / I-kB-a and Crucial To EGF Protection of Cytoskeletal Assembly and Barrier Function (BF) in Intestinal Monolayers. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Banan A, Zhang L, Shaikh M, Farhadi A, Fields JZ, Keshavarzian A. Atypical Lambda (l) Isoform of PKC Is A unique Mediator of F-Actin Cytoskeletal Disassembly & Instability and Key in Oxidative Damage to Monolayers of intestinal cells. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 126 (4, supp1): M1634, 2004.
¨ Bansal PJ, Moparty B, DeMeo MT, Farhadi A, Keshavarzian A, Tobin MC. Atopic dermatitis as an allergic marker for irritable bowel syndrome. J Allergy and Clin Immunol, 111 (1, Supp 2): S157, 2003.
¨ Farhadi A, Sotil E, Sheikh M, Banan A, Keshavarzian A. Is mucosal mast cell in subjects with inflammatory bowel disease different from healthy controls? Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro 98 (9, supp1), S254, 2003.
¨ Farhadi A, Banan A, Zhang L, Keshavarzian A. Colonic Mucosal Protein Oxidation Induced by Cold Pressor Stress Test in Patients with Inflammatory Bowel Disease; A Possible Contributing Factor in the Pathogenesis and disease flare-up. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro 98(9, supp1), S253-4, 2003.
¨ Farhadi A, Jakate S, Fields J, Zhang L, Banan A, Keshavarzian A. A New Approach to Intestinal Morphometric Studies: Application to the Assessment of Mucosal Mast Cell Population Size. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro 98(9, supp1), S253, 2003.
¨ Farhadi A, Fields J, Shaikh M, Banan A, Keshavarzian A. Exaggerated Response to Physiological Stress in Patients with IBD; A Possible Contributing Factor in the Pathogenesis of IBD. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro 98(9, supp1), S253, 2003.
¨ Swanson G, Farhadi A, Banan A, Mutlu E, Cotler S, Keshavarzian A. Increase in Urinary Neoptrin in Alcoholic Liver Disease after Aspirin Challenge as a Signal of Altered Intestinal Permeability. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): M1634, 2003.
¨ Bhvanni M, Tobin MC, DeMeo MT, Farhadi A, Keshavarzian A. A subgroup of irritable Bowel Syndrome patients with atopic disease “Atopic IBS”. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. May, 2003 Orlando, FL.
¨ Banan A, Zhang L, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Evidence That NF-kB Activation Is Critical to Oxidant Disruption of Cytoskeleton & Barrier integrity (BI) and That its Inactivation is key to EGF Protection of Monolayers of Intestinal Epithelia. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): 858, 2003.
¨ Banan A, Shaikh M, Zhang L, Fields JZ, Farhadi A, Keshavarzian A. Upregulation of NF-kB, iNOS, and Cytoskeletal Protein Oxidation and Dysfunction in Colonic Mucosa of Patients with Inflammatory Bowel Disease. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): S1338, 2003.
¨ Banan A, Fields JZ, Farhadi A, Zhang L, Shaikh M, Keshavarzian A. The Novel Delta (d) Isoform of PKC Causes iNOS & NO Upregulation: A Unique Mechanism for Oxidant-induced Carbonylation & Disassembly of the Cytoskeleton and Disruption of Barrier of Intestinal Epithelia. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): T906, 2003.
¨ Banan A, Zhang L, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Zeta (z) Isoform of PKC Is A Unique Modulator of NF-kB / I-kB-a in The Intestinal Epithelium & Critical to Monolayer Protection. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): T1044, 2003.
¨ Banan A, Fields JZ, Zhang L, Shaikh M, Farhadi A, Keshavarzian A. Atypical Lambda (l) Isoform of PKC (PKC-l) Is A Novel Mediator of Intestinal Barrier Disruption & Cytoskeletal Disassembly and Essential in Oxidative Cellular Injury. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): M1126, 2003.
¨ Banan A, Fields JZ, Zhang L, Farhadi A, Shaikh M, Keshavarzian A. Key role of Phospholipase C-g1 Isoform in EGF Protection of F-actin Cytoskeleton & Intestinal Barrier Integrity (BI) against Oxidant-Induced iNOS Upregulation. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): M1122, 2003.
¨ Banan A, Farhadi A, Shaikh M, Zhang L, Fields JZ, Keshavarzian A. Increases in iNOS, Free Radicals and Cytoskeletal Protein Oxidation & Nitration in Intestinal Mucosa of Patients with Alcoholic Liver Disease (ALD). Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterology, 124 (4, supp1): M1633, 2003.
¨ Katz RS, Farhadi A, Moss R, Gasich L, Ranjbaran J, Katz A. Statin associated muscle complaints: Myth or fact?. Presentation at the 67th Annual Meeting of the American college of Rheumatology, Oct. 2003 Orlando, FL.
¨ Katz RS, Farhadi A, Hoffman M. treatment of pyoderma gangrenosum with Infliximab. Presentation at the 67th Annual Meeting of the American college of Rheumatology, Oct. 2003 Orlando, FL.
¨ Bansal PJ, Moparty B, DeMeo MT, Farhadi A, Keshavarzian A, Tobin MC. Atopic Dermatitis as an Allergic Marker for Irritable Bowel Syndrome. Annual Meeting of American Academy of Allergy, Asthma and Immunology, 60th Anniversary Meeting. March, 2003 Denver, CO.
¨ Farhadi A, Jakate S, Zhang L, Bakaites M, Banan A, Keshavarzian A. Differing response of mucosal mast cells to stress in IBD and controls. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 97(9): S253, 2002.
¨ Domm A, Farhadi A, Jakate S, Bakaites M, Banan A, Keshavarzian A. Intestinal Mast cell activation and degranulation following physiological stress in IBD; Electron Microscopy study. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 97(9): S255-6, 2002.
¨ Prendiville SS, Hagle T, Farhadi A, Brand M, Saclarides T, Keshavarzian A. Aggressive use of examination under anesthesia in symptomatic perianal Crohn’s disease reduces the infectious perianal complications of remicade. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 97(9): S268, 2002.
¨ Farhadi A, Keshavarzian A, Holms E, Zhang L, Banan A. A novel gas chromatographic method for detection of urinary Sucralose: Application to the assessment of intestinal permeability. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 97(9): S79-80, 2002.
¨ Aneziokoro AE, Zhang L, Banan A, Farhadi A, Cotler S, Jakate S, Keshavarzian A. Endotoxemia and increased TNF in alcoholic liver disease are essential factor for the initiating alcohol-induced liver disease. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 97(9): S91, 2002.
¨ Tobin MC, Moparty B, Farhadi A, DeMeo MT, Keshavarzian A. Atopic IBS, a subgroup of IBS with atopic symptoms. Annual Meeting of Allergy, Asthma and Immunology, Nov 2002, San Antonio, TX.
¨ Banan A, Fields JZ, Farhadi A, Zhang L, Keshavarzian A. z isoform of Protein Kinase C (PKC-z) is a novel modulator of intestinal barrier integrity and cytoskeletal assembly and key in cellular protection. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 122(4): M1132, 2002.
¨ Banan A, Farhadi A, Fields JZ, Zhang L, Keshavarzian A. Role of phospholipase C signaling in EGF Protection of intestinal barrier integrity & F-Actin Dynamic assembly: Requirement for Tyrosine phosphorylation & activation of the g isoform of PLC. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 122(4): T863, 2002.
¨ Banan A, Fields JZ, Farhadi A, Zhang L, Keshavarzian A. EGF Protects intestinal barrier integrity by stabilizing microtubule assembly: role of PKC-z isoform signaling & iNOS down-regulation. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 122(4): M1156, 2002.
¨ Banan A, Farhadi A, Fields JZ, Zhang L, Keshavarzian A. EGF Protects intestinal barrier integrity by stabilizing F-Actin Dynamics: role of PKC-b 1 isoform signal activation and Ca homeostasis. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 122(4): S833, 2002.
¨ Banan A, Fields JZ, Farhadi A, Zhang L, Keshavarzian A. PKC-d could explain how oxidants disrupt the microtubule cytoskeleton and injure monolayers of intestinal epithelia. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 122(4): 771, 2002.
¨ Farhadi A, Banan A, Fields JZ, Zhang L, Keshavarzian A. Stimulated neutrophil cause disassembly & instability of cytoskeleton and disruption of barrier integrity of human intestinal epithelia. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. May, 2002 San Francisco, Ca.
¨ Aneziokoro AE, Farhadi A, Bakaites M, Banan A, Zeidi S, Cotler S, Keshavarzian A. Susceptibility of the small and large bowel to leakiness is a factor in alcoholics with liver disease. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 122(4): M1358, 2002.
¨ Farhadi A, Fields J. Assessment of esophagogastroduodenoscopy tolerance: A prospective study of 300 cases. Presentation at the Annual scientific meeting of American Gastroenterological Association, Digestive Disease week. Gastroenterol, Vol 120(5): 1304, 2001.
¨ Farhadi A, Keshavarzian A, Banan A, Zhang Y, Fitzpatrick LF. The modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on OPC antioxidant. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 96(9): S290, 2001.
¨ Kaplan M, Banan A, Mutlu E, Mallavarapu R, Zhang L, Farhadi A, Keshavarzian A. Protection by commonly used herbs against oxidant-induced cell injury in a human colonic cell line. Presentation at the Annual Scientific Meeting of the American College of Gastroenterology. Am J Gastro , Vol 96(9): S296, 2001.
¨ Zali MR, Mohammed K, Farhadi A, Masjedi MR, Zargar A, Noroozi A. Epidemiology of hepatitis B in Islamic Republic of Iran. Poster presentation at the 10th International Symposium on Viral Hepatitis. Atlanta April 2000.